Globus Medical, Inc.

184 articles about Globus Medical, Inc.

• Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis

  5/15/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced the REFLECT™ Scoliosis Correction System has been granted approval from the US Food and Drug Administration, as the company’s first humanitarian device.

• Globus Medical Reports First Quarter 2023 Results

  5/4/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended March 31, 2023.

• Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

  4/27/2023

  Globus Medical, Inc. announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive.

• Globus Medical Schedules First Quarter 2023 Earnings Release and Conference Call

  4/19/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023.

• Globus Medical Reports Fourth Quarter and Full Year 2022 Results

  2/21/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the fourth quarter and year ended December 31, 2022.

• Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

  2/9/2023

  Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction.

• Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

  2/2/2023

  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023.

• Globus Medical Reports Third Quarter 2022 Results

  11/8/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended September 30, 2022.

• Globus Medical Schedules Third Quarter Earnings 2022 Release and Conference Call

  10/19/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2022 after the market close on Tuesday, November 8, 2022.

• Globus Medical Reports Second Quarter 2022 Results

  8/4/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended June 30, 2022.

• Globus Medical Schedules 2022 Second Quarter Earnings Release and Conference Call

  7/18/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 4, 2022.

• Globus Medical Announces First Surgeries Using Excelsius3D™Intraoperative 3D Imaging System Advances Robotic Navigation Spine Surgery

  5/18/2022

  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first surgeries performed with the Excelsius3D™, an intelligent, intraoperative 3-in-1 imaging platform, the latest addition to Globus Medical’s Excelsius™ Ecosystem.

• Globus Medical Reports First Quarter 2022 Results

  5/10/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the first quarter ended March 31, 2022.

• Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results

  4/21/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced the resignation of President and Chief Executive Officer, Dave Demski, after nearly 20 years with the company, with the last four and a half years as its CEO.

• Globus Medical Announces the Expansion of its Share Repurchase Program

  3/4/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced that its Board of Directors has expanded the Company’s share repurchase program by authorizing the repurchase of an additional $200 million of the Company’s common stock.

• Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

  1/27/2022

  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2021 after the market close on Thursday, February 17, 2022.

• Globus Medical Reports Third Quarter 2021 Results

  11/4/2021

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended September 30, 2021.

• Globus Medical Premieres ANTHEM® Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting

  10/19/2021

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced it will feature its new ANTHEM® Mini Fragment Fracture System at the annual Orthopaedic Trauma Association meeting in Fort Worth, Texas, Oct 20-23, 2021.

• Globus Medical Schedules Third Quarter Earnings Release and Conference Call

  10/14/2021

  Globus Medical , Inc. will announce its financial results for the third quarter ended September 30, 2021 after the market close on Thursday, November 4, 2021.

• Globus Medical to Participate in North American Spine Society Annual MeetingUnveiling Excelsius3D™ Intelligent Imaging System

  9/28/2021

  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate in the 36th Annual Meeting of the North American Spine Society (NASS) being held September 29 through October 2, 2021 at the Boston Convention and Exhibition Center.